Wiita and colleagues use cross-linking mass spectrometry and glycoprotein surface capture to identify an activated conformation of integrin β2 present on AML cells and develop CAR T cells that target this conformation antigen in preclinical models.
- Kamal Mandal
- Gianina Wicaksono
- Arun P. Wiita
